S&P 500
(-0.16%) 5 464.62 points
Dow Jones
(0.04%) 39 150 points
Nasdaq
(-0.18%) 17 689 points
Oil
(-1.86%) $80.64
Gas
(-1.17%) $2.71
Gold
(-1.42%) $2 335.30
Silver
(-4.01%) $29.59
Platinum
(1.23%) $996.40
USD/EUR
(0.12%) $0.935
USD/NOK
(0.27%) $10.57
USD/GBP
(0.08%) $0.791
USD/RUB
(2.12%) $89.12

Realtime updates for Essex Bio-Technology Ltd [1061.HK]

Exchange: HKSE Sector: Biotechnology Industry: Biotechnology
Last Updated21 Jun 2024 @ 03:59

1.22% HKD 2.48

Live Chart Being Loaded With Signals

Commentary (21 Jun 2024 @ 03:59):
Our systems believe the stock currently is overvalued by 0.00% compare to its pairs and should correct downwards.

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally...

Stats
Today's Volume 188 000
Average Volume 142 593
Market Cap 1.41B
EPS HKD0.190 ( Q4 | 2023-12-31 )
Last Dividend HKD0.0450 ( 2023-08-29 )
Next Dividend HKD0 ( N/A )
P/E 5.28
(Sector) 0
(Industry) 6.31
ATR14 HKD0.0360 (1.45%)
0690.HK 7.94%
1061.HK 1.22%
1167.HK 0.00%
1177.HK -3.35%
1228.HK -8.33%
1477.HK 1.48%
1521.HK -3.19%
1530.HK -0.33%
1548.HK -1.39%
1672.HK -1.10%
1873.HK 0.00%
1875.HK -12.79%
1877.HK -1.91%
1952.HK -1.00%
2096.HK -1.73%
2126.HK 1.97%
2137.HK 0.00%
2142.HK -3.82%
2157.HK 0.25%
2162.HK 4.85%
2171.HK -2.81%
2179.HK 0.00%
2197.HK 1.39%
2256.HK -0.64%
2257.HK 4.06%
2616.HK 1.87%
2696.HK 4.67%
3759.HK 0.44%
6160.HK -1.67%
6600.HK 0.86%
6622.HK 1.44%
6628.HK 2.17%
6821.HK -0.40%
6826.HK -1.31%
6978.HK 1.94%
6996.HK 0.00%
6998.HK -1.67%
9688.HK -1.43%
9926.HK 0.42%
9939.HK -2.65%
9966.HK -2.27%
9969.HK 4.40%
9995.HK -1.13%
Correlation (AI algo v.1.1b): Overvalued: 0.00% HKD2.48 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Essex Bio-Technology Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Essex Bio-Technology Ltd Financials

Annual 2023
Revenue: HKD1.71B
Gross Profit: HKD1.54B (90.20 %)
EPS: HKD0.480
FY 2023
Revenue: HKD1.71B
Gross Profit: HKD1.54B (90.20 %)
EPS: HKD0.480
FY 2022
Revenue: HKD1.32B
Gross Profit: HKD1.19B (90.26 %)
EPS: HKD0.390
FY 2021
Revenue: HKD1.64B
Gross Profit: HKD1.40B (85.23 %)
EPS: HKD0.600

Financial Reports:

No articles found.

Essex Bio-Technology Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0400
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0250
(N/A)
HKD0.0450
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Essex Bio-Technology Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.61 - Stable (32.17%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.0100 2009-04-30
Last Dividend HKD0.0450 2023-08-29
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 21 --
Total Paid Out HKD0.602 --
Avg. Dividend % Per Year 0.00% --
Score 3.65 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.61
Div. Directional Score 9.79 --
Next Divdend (Est)
(2025-01-27)
HKD0.0467 Estimate 11.67 %
Dividend Stability
0.47 Below Average
Dividend Score
3.65
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
29 Aug 2023 HKD0.0450 30 Nov -0001 30 Nov -0001 30 Nov -0001
13 Jun 2023 HKD0.0250 30 Nov -0001 30 Nov -0001 30 Nov -0001
05 Sep 2022 HKD0.0400 30 Nov -0001 30 Nov -0001 30 Nov -0001
04 May 2022 HKD0.0550 30 Nov -0001 30 Nov -0001 30 Nov -0001
30 Aug 2021 HKD0.0400 30 Nov -0001 30 Nov -0001 30 Nov -0001
14 May 2021 HKD0.0500 30 Nov -0001 30 Nov -0001 30 Nov -0001
14 May 2020 HKD0.0500 17 Mar 2020 15 May 2020 02 Jun 2020
29 Aug 2019 HKD0.0350 12 Aug 2019 30 Aug 2019 20 Sep 2019
03 May 2019 HKD0.0330 11 Mar 2019 06 May 2019 27 May 2019
03 Sep 2018 HKD0.0300 08 Aug 2018 04 Sep 2018 21 Sep 2018
15 May 2018 HKD0.0250 15 Mar 2018 16 May 2018 01 Jun 2018
28 Sep 2017 HKD0.0250 11 Aug 2017 29 Sep 2017 20 Oct 2017
09 May 2017 HKD0.0320 21 Mar 2017 10 May 2017 26 May 2017
11 May 2016 HKD0.0250 18 Mar 2016 12 May 2016 27 May 2016
13 May 2015 HKD0.0220 18 Mar 2015 14 May 2015 27 May 2015
12 May 2014 HKD0.0180 07 Mar 2014 13 May 2014 26 May 2014
09 May 2013 HKD0.0100 22 Mar 2013 10 May 2013 27 May 2013
10 May 2012 HKD0.0120 23 Mar 2012 11 May 2012 28 May 2012
28 Apr 2011 HKD0.0100 28 Mar 2011 29 Apr 2011 19 May 2011
04 May 2010 HKD0.0100 25 Mar 2010 05 May 2010 24 May 2010

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3300.HK No Dividend Player 2023-08-02 Sporadic 0 0.00%
0960.HK Ex Dividend Knight 2023-12-29 Semi-Annually 0 0.00%
2005.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
0586.HK Ex Dividend Junior 2023-06-29 Annually 0 0.00%
1606.HK Ex Dividend Junior 2023-06-30 Annually 0 0.00%
0194.HK Ex Dividend Junior 2023-09-01 Semi-Annually 0 0.00%
3993.HK Ex Dividend Knight 2023-06-29 Annually 0 0.00%
1184.HK Ex Dividend Knight 2023-09-21 Semi-Annually 0 0.00%
2318.HK Ex Dividend Knight 2023-09-11 Semi-Annually 0 0.00%
0777.HK Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1611.5006.7710.00[0 - 0.5]
returnOnAssetsTTM0.09731.2006.768.11[0 - 0.3]
returnOnEquityTTM0.1481.5009.4710.00[0.1 - 1]
payoutRatioTTM0.145-1.0008.55-8.55[0 - 1]
currentRatioTTM1.5360.8007.325.86[1 - 3]
quickRatioTTM1.4250.8006.325.06[0.8 - 2.5]
cashRatioTTM0.6331.5007.5910.00[0.2 - 2]
debtRatioTTM0.0968-1.5008.39-10.00[0 - 0.6]
interestCoverageTTM21.841.0003.023.02[3 - 30]
operatingCashFlowPerShareTTM0.5882.009.8010.00[0 - 30]
freeCashFlowPerShareTTM0.3632.009.8210.00[0 - 20]
debtEquityRatioTTM0.142-1.5009.43-10.00[0 - 2.5]
grossProfitMarginTTM0.9021.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.1851.0008.298.29[0.1 - 0.6]
cashFlowToDebtRatioTTM1.2201.0004.334.33[0.2 - 2]
assetTurnoverTTM0.6040.8009.317.45[0.5 - 2]
Total Score12.97

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM5.261.0009.570[1 - 100]
returnOnEquityTTM0.1482.509.6610.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.3632.009.8810.00[0 - 30]
dividendYielPercentageTTM4.511.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.5882.009.8010.00[0 - 30]
payoutRatioTTM0.1451.5008.55-8.55[0 - 1]
pegRatioTTM0.3911.500-0.7290[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1961.0007.610[0.1 - 0.5]
Total Score6.61

Essex Bio-Technology Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Essex Bio-Technology Ltd

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.7688221931458 seconds
Number of API calls: 3
Number of DB calls: 9